INTERGRATED DIA.H DL 025 (8I8) - Cash Flow Conversion Efficiency
Based on the latest financial reports, INTERGRATED DIA.H DL 025 (8I8) has a cash flow conversion efficiency ratio of 0.096x as of June 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€340.79 Million ≈ $398.42 Million USD) by net assets (€3.55 Billion ≈ $4.15 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 8I8 equity financing ratio to measure how much of total assets are equity-financed.
INTERGRATED DIA.H DL 025 - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how INTERGRATED DIA.H DL 025's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is INTERGRATED DIA.H DL 025's earnings quality to evaluate the quality of earnings relative to operating cash generation.
INTERGRATED DIA.H DL 025 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of INTERGRATED DIA.H DL 025 ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BRT Realty Trust
NYSE:BRT
|
0.012x |
|
Ningbo Tianyi Medical Appliance Co. Ltd.
SHE:301097
|
N/A |
|
Kingsway Financial Services Inc
NYSE:KFS
|
0.041x |
|
Sunlour Pigment CO.LTD.
SHE:301036
|
N/A |
|
TWFG, Inc. Class A Common Stock
NASDAQ:TWFG
|
0.051x |
|
Bangkok Land Public Company Limited
BK:BLAND-R
|
0.003x |
|
Shanghai Chlor-Alkali Chemical Co Ltd B
SHG:900908
|
0.014x |
|
Eveready Industries India Limited
NSE:EVEREADY
|
0.066x |
Annual Cash Flow Conversion Efficiency for INTERGRATED DIA.H DL 025 (2021–2025)
The table below shows the annual cash flow conversion efficiency of INTERGRATED DIA.H DL 025 from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see market value of INTERGRATED DIA.H DL 025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €4.13 Billion ≈ $4.83 Billion |
€1.90 Billion ≈ $2.23 Billion |
0.461x | +2.86% |
| 2024-12-31 | €3.50 Billion ≈ $4.09 Billion |
€1.57 Billion ≈ $1.83 Billion |
0.448x | +155.65% |
| 2023-12-31 | €3.10 Billion ≈ $3.63 Billion |
€543.66 Million ≈ $635.60 Million |
0.175x | +105.54% |
| 2022-12-31 | €2.45 Billion ≈ $2.86 Billion |
€208.73 Million ≈ $244.03 Million |
0.085x | -89.50% |
| 2021-12-31 | €2.79 Billion ≈ $3.27 Billion |
€2.27 Billion ≈ $2.65 Billion |
0.812x | -- |
About INTERGRATED DIA.H DL 025
Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron… Read more